Clinical Trial Update: Beta Blocker Therapy in Mild to Moderate Asthmatics [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating beta blocker therapy in mild to moderate asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 2 | Status: COMPLETED